Skip to content

To Study The Effect Of Virechan Karma And Narikel Khand Pak In Amlapitta With Special Reference To Hyperacidity

Randomized Clinical Study Of Virechan Karma And Narikel Khand Pak In Amlapitta With Special Reference To Hyperacidity - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071038
Enrollment
80
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

LRP Ayurvedic Hospital And Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient will be selected irrespective of gender occupation and habitat. 2.Those who are fit for virechan procedure. 3.Patients presenting with classic sign and symptoms of Amlapitta.

Exclusion criteria

Exclusion criteria: 1.Age below 20 years and above 60 years. 2.Those who are not fit for Virechan procedure. 3.Patient having history of hyper acidity due to secondary underling cause like oesophageal carcinoma. 4.Patients diagnosed with gastric and duodenal ulcer.

Design outcomes

Primary

MeasureTime frame
To Study The Effect Of Virechan Karma And Narikel Khand Pak In AmlapittaTimepoint: 48 days

Secondary

MeasureTime frame
To Reduce the Almapitta in 48 days To study the literature related to concept of Amlapitta To study the concept of virechan karma To study the concept of Narikel khand Pak Timepoint: 12 months

Countries

India

Contacts

Public ContactDr Vinay chavan

LRP Ayurvedic medical college and hospital

purvachavan007@gmail.com9511845191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026